About this trial
Spontaneous coronary artery dissection (SCAD) is an increasingly recognised cause of non-atherosclerotic acute coronary syndromes (ACS), predominantly afflicting young women without conventional atherosclerotic risk factors. Knowledge of SCAD has advanced considerably in the last few years as a result of data from a number of local and national registries 1-6. Like all rarer diseases however, a better understanding of SCAD will require international collaboration. At present, there is no European or International SCAD registry despite increasing recognition that there are key differences in the diagnosis, interventional and medical management of SCAD compared with conventional atherosclerotic ACS. The ESC-ACCA Study Group on Spontaneous Coronary Artery Dissection supported by the European Observational Research Programme will now build the first pan-European SCAD registry to advance our understanding of current management of this condition, inform guidelines, educate clinical colleagues and advance research.
Eligibility criteria
Qualifiers
Patient having signed an Informed Consent
Patient aged 18 years and over
SCAD clinical diagnosis within the past 10 years and available coronary angiographic imagery
Disqualifiers
Patient unwilling or unable to consent
Patients with iatrogenic or atherosclerotic coronary dissection
Trial design
Treatments tested in this trial
- There are no interventions as the study is purely observational.